Seeking Alpha

Seeking Alpha Portfolio App for iPad

Kinetic Investments

Kinetic Investments picture

Kinetic Investments

Profile

Send Message

View as an RSS Feed

View Kinetic Investments' Articles BY TICKER:

MannKind: A Long and Costly Road Ahead
on Tue, May 10, 2011 • MNKD • 13 Comments
Avanir Pharmaceuticals' Possible and Unofficial Sales Guidance Is Good for Long-Term Investors
on Wed, May 4, 2011 • AVNR • 21 Comments
GTx Roaring Into Earnings: Potential Short-Term Momentum Play
on Tue, May 3, 2011 • GTXI • 4 Comments
Spectrum Pharma: Yet Another Bio Flash Crash Ahead of an FDA Decision
on Tue, May 3, 2011 • SPPI • 15 Comments
Dendreon's Q1 Earnings Preview: Meet, Beat, or Miss?
on Fri, Apr 29, 2011 • DNDN • 9 Comments
Jazz Pharmaceuticals: Another Healthcare Sector Flash Crash, Stop-Limits Triggered
on Wed, Apr 27, 2011 • JAZZ • 6 Comments
Avanir Pharma Begins to Demonstrate Its Relevance; Shares Surge on Heavy Volume
on Mon, Apr 25, 2011 • AVNR • 15 Comments
Zalicus: Is Wall Street Wise to Its Long-Term Potential?
on Wed, Apr 20, 2011 • ZLCS • 4 Comments
Amylin: Diabetes Drug Bydureon Closer to EU Approval
on Mon, Apr 18, 2011 • ALKS, LLY, NVO • Comment!
Amarin: Market Seems to Be Anticipating Positive ANCHOR Trial Data
on Thu, Apr 14, 2011 • AMRN, GSK • 35 Comments
Exelixis: Preparing to be Purchased?
on Tue, Apr 12, 2011 • EXEL • 4 Comments
Vertex Pharmaceuticals: Telaprevir a Likely Lock for Approval
on Mon, Apr 11, 2011 • VRTX, DNDN, OREX • 6 Comments
XenoPort: Waiting for the Post-Approval Dust to Settle
on Fri, Apr 8, 2011 • XNPT • 6 Comments
Star Scientific's Stock Is Smoking: Will Shares Come Down to Earth?
on Wed, Apr 6, 2011 • STSI • 32 Comments
Dendreon: Mammoth Potential Despite Drama
on Mon, Apr 4, 2011 • DNDN • 12 Comments
FDA Insider Trading: Time for an Overhaul?
on Thu, Mar 31, 2011 • MNKD, POZN, VNDA • 8 Comments
Avanir Pharmaceuticals: Uncovering Nuedexta's Potential Part II
on Mon, Mar 28, 2011 • AVNR • 7 Comments
Avanir Pharmaceuticals: Uncovering Nuedexta's Potential Part I
on Sun, Mar 27, 2011 • AVNR • 17 Comments
Atmel: Recent Market Pullback Presents an Opportunity
on Thu, Mar 24, 2011 • ATML, NVDA, GOOG • 3 Comments
Ariad Pharmaceuticals: Solid Company but Not a Steal
on Mon, Mar 21, 2011 • ARIA • 3 Comments
Star Scientific: A Struggling Tobacco Company Sitting on a Healthcare Gold Mine?
on Mon, Mar 14, 2011 • STSI, RAI • 20 Comments
Avanir Pharmaceuticals: Full Steam Ahead
on Tue, Mar 8, 2011 • AVNR • 30 Comments
Will Netflix Continue to Stream Gains Into Your Portfolio in 2011?
on Tue, Feb 8, 2011 • NFLX, AAPL, AMZN • 30 Comments
Could Avanir Pharmaceuticals Become a 2011 Takeover Target?
on Mon, Jan 31, 2011 • AVNR • 15 Comments
Somaxon Pharmaceuticals: Will FDA Approval Ever Pay Off?
on Wed, Jan 26, 2011 • SOMX, PG • 6 Comments
Mannkind: Of Bio Flash Crashes and Stop Limits
on Wed, Jan 19, 2011 • MNKD • 14 Comments
The Market Seems to Disagree With Alexza's Promising News
on Wed, Jan 19, 2011 • ALXA • 1 Comment
How Much Upside Potential Does Atmel Still Have?
on Mon, Jan 17, 2011 • ATML, AAPL, SSNLF.PK • 3 Comments
Avanir Pharmaceuticals Poised for a Strong New Drug Launch
on Sun, Jan 9, 2011 • AVNR • 37 Comments